[FORM 12b-25 NOTIFICATION OF LATE FILING CUSIP NUMBER: 090678 301 o o o (Check One): x o o For Period Ended: June 30, 2017 o o o o o For the Transition Period Ended: ____________________ Nothing in this form shall be construed to imply that the Commission has verified any information contained herein]
[Sinovac Biotech Announces Certain Updates Relating to Delayed Filing of Annual Report on Form 20-F BEIJING, Aug. 14, 2017 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today that The NASDAQ Stock ]
[Sinovac Biotech Announces Certain Updates Relating to Delayed Filing of Annual Report on Form 20-F BEIJING, Aug. 14, 2017 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today that The NASDAQ Stock ]
[W ashington FORM 8-A Amendment No. 2 FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES SINOVAC BIOTECH LTD. Antigua, West Indies Not Applicable (State or other jurisdiction (I.R.S. Employer Identification of incorporation or organization) Number) No. 39 Shangdi Xi Road, Haidian District, Beijing 100]
[SINOVAC BIOTECH LTD. and PACIFIC STOCK TRANSFER COMPANY as Rights Agent SECOND AMENDMENT TO RIGHTS AGREEMENT Effective as of June 26, 2017 Amendment Rights Agreement Company Rights Agent Amalgamation Agreement Parent provided however This Second Amendment (this “ WHEREAS, the Company and the Rights ]
[SINOVAC BIOTECH LTD. and PACIFIC STOCK TRANSFER COMPANY as Rights Agent SECOND AMENDMENT TO RIGHTS AGREEMENT Effective as of June 26, 2017 Amendment Rights Agreement Company Rights Agent Amalgamation Agreement Parent provided however This Second Amendment (this “ WHEREAS, the Company and the Rights ]
[Joint Filing Agreement This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument. [Remainder of this page has been left intentionally blank.] SAIF Partners IV L.P. Andrew Y. Yan Director of SAIF IV GP Capital Ltd., which is]
[Execution Version INTERIM INVESTORS AGREEMENT Agreement Holdco Parent Amalgamation Sub This Interim Investors Agreement (the “ RECITALS Company Amalgamation Agreement Amalgamation WHEREAS, on the date hereof, Sinovac Biotech Ltd., an Antigua and Barbuda company (the “ C-Bridge Advantech Vivo Capital]
[Sinovac Biotech Announces Receipt of NASDAQ Letter and Delayed Filing of Annual Report on Form 20-F BEIJING, May 16, 2017 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA)(“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today that it is delaying its]
[FORM 12b-25 NOTIFICATION OF LATE FILING CUSIP NUMBER: 090678 301 o o o (Check One): x o o For Period Ended: March 31, 2017 o o o o o For the Transition Period Ended: ____________________ Nothing in this form shall be construed to imply that the Commission has verified any information contained herei]
